Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin in Progressive Low-Grade Gliomas
NCT00002749Phase 2Completed
- Sponsor
- Duke University
- Start
- Feb 1993
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of carboplatin in glioma, sponsored by Duke University. Primary endpoint: Response to carboplatin. Started Feb 1993; status: completed.
02
Drugs
carboplatin
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00002749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002749.